Antoine Azar

Medicine & Life Sciences

1. Primary Immunodeficiency Diseases 100%
2. Allergic Rhinitis 95%
3. Chronic Obstructive Pulmonary Disease 92%
4. Hypersensitivity 90%
5. Common Variable Immunodeficiency 82%
6. Antibodies 71%
7. Asthma 67%
8. Nasal Polyps 67%
9. Sublingual Immunotherapy 61%
10. Immunotherapy 57%
11. Immunologic Deficiency Syndromes 54%
12. Systemic Lupus Erythematosus 48%
13. benralizumab 47%
14. Therapeutics 43%
15. pegaptanib 42%
16. Immunoglobulin G 41%
17. Agammaglobulinemia 40%
18. Immunologic Desensitization 39%
19. Passive Immunization 38%
20. Systematic Reviews 38%
21. SARS Virus 38%
22. anti-thyroglobulin 36%
23. Lebanon 35%
24. Thyroid Neoplasms 34%
25. Chronic Granulomatous Disease 34%
26. Autonomic Pathways 34%
27. Immunologic Tests 33%
28. Quality of Life 33%
29. Pemphigus 32%
30. Rabies 32%
31. Cyclosporine 32%
32. Follicular Lymphoma 31%
33. Cystitis 31%
34. Lymphoproliferative Disorders 30%
35. Myasthenia Gravis 30%
36. Lung Transplantation 30%
37. beta-Lactams 29%
38. Infections 28%
39. Interstitial Lung Diseases 28%
40. Sirolimus 27%
41. Airway Obstruction 27%
42. Placebos 26%
43. Autoimmune Diseases 26%
44. Human Herpesvirus 4 25%
45. Biological Products 25%
46. Double-Blind Method 25%
47. Thyroglobulin 24%
48. Consensus 24%
49. Arthroplasty 24%
50. Immunoglobulin A 24%